跳至主要内容
临床试验/NCT03857932
NCT03857932招募中不适用

Clinical Study on Regularity of Lymphatic Drainage and Surgical Treatment of Breast Cancer

Shandong University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Disease free survival

研究概览

简要总结

The investigatorsconduct the precise sentinel lymph node biopsy using preoperative computed tomographic lymphography in breast cancer. The investigators aimed to summarize the law of lymphatic drainage of breast, and to conduct the accurate surgical treatment of breast cancer.

详细描述

AIM:Sentinel lymph node biopsy (SLNB) is the standard technique for patients with early stage breast cancer. The investigators conduct the precise sentinel lymph node biopsy using preoperative computed tomographic lymphography in breast cancer. And The investigators identify the true sentinel lymph nodes(SLNs) followed by lymphatic ducts during operation. The investigators aimed to identify the non-sentinel lymph node, and to investigate the relationship between upper extremity lymphatic drainage. The SLNB procedure could avoid unnecessary lymph node resection and reduce treatment-related sequela.

Arm1:

  1. Participants received preoperative computed tomographic lymphography
  2. Participants received sentinel lymph node biopsy(SLNB)
  3. Participants received stained non-sentinel lymph node resection during SLNB
  4. Participants received axillary reverse mapping dissection Arm2: Participants receive sentinel lymph node biopsy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •histologically confirmed primary breast cancer by core needle biopsy or excisional biopsy
  • •abnormal para-sentinel lymph node was found by ultrasound examination
  • •ultrasound-guided fine needle aspiration cytology of these nodes were performed
  • •the result of fine needle aspiration cytology was negative (no tumour cell was found)
  • •participants planed to perform SLNB

排除标准

  • •pathological diagnosed ductal carcinoma in situ by excisional biopsy
  • •the result of fine needle aspiration cytology was positive
  • •participants has received neo-adjuvant system therapy

研究组 & 干预措施

SLNB and non-slns resection

Experimental
  1. Participants only receive SLNB
  2. preoperative CT lymphography
  3. SLNB with stained non-SLN resection
  4. SLNB with ARM dissection

干预措施: Participants receive SLNB as well as non SLNs resection (Procedure)

SLNB group

Experimental

Participants only receive SLNB

干预措施: Participants receive SLNB as well as non SLNs resection (Procedure)

结局指标

主要结局

Disease free survival

时间窗: Up to 10 years

Time from randomization to recurrence, metastasis, appearance of a second primary tumor, or death from any cause, whichever occurs first, assessed up to 10 years.

次要结局

  • Overall survival(Up to 10 years)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qifeng Yang

Professor

Shandong University

研究点 (1)

Loading locations...

相似试验